Company Filing History:
Years Active: 2018-2021
Title: Innovator Spotlight: Shimaa Eissa from Riyadh
Introduction
Shimaa Eissa is a renowned inventor based in Riyadh, Saudi Arabia. She has made significant contributions to the field of biosensors with a portfolio that includes four patents. Her innovative work primarily focuses on the development of advanced detection methods for critical health-related applications.
Latest Patents
Among her notable inventions, Shimaa's latest patents are groundbreaking in the realm of immunosensors. One of her key patents describes a method and process to make and use a cotton-tipped electrochemical immunosensor for the detection of coronavirus. This invention revolutionizes pathogen detection by utilizing carbon nanofiber-modified screen printed electrodes, which are functionalized and activated through sophisticated chemical methods. The resulting electrochemical biosensors demonstrate exceptional sensitivity, with limits of detection of 0.8 and 0.09 pg/ml for SARS-CoV-2 and MERS-CoV, respectively. Importantly, her biosensors exhibit high selectivity, showing minimal cross-reactivity with other viral antigens, which is crucial for accurate diagnostics.
Another significant patent involves the development of full-length and truncated anti-coagulant Dabigatran etexilate specific DNA aptamers for both electrochemical and fluorescence sensing applications. These aptamers, selected through intensive rounds of analysis with a randomized DNA library, display impressive binding affinity and specificity. The innovative use of fluorescent markers for mapping binding regions further enhances the potential applications of these aptamers in therapeutic monitoring and clinical diagnostics.
Career Highlights
Shimaa Eissa is affiliated with Alfaisal University, where she has been able to integrate her research into her role as an innovator. Her academic contributions and inventive work have gained recognition for their potential impact on healthcare diagnostics.
Collaborations
Throughout her career, Shimaa has collaborated with esteemed colleagues such as Mohammed Zourob and Raja Chinnappan. These partnerships highlight the importance of teamwork in advancing research and innovation within their field.
Conclusion
Shimaa Eissa exemplifies the spirit of innovation through her patents and contributions to biosensor technologies. Her work not only enhances detection methods for viruses but also paves the way for new clinical applications that could benefit public health. As she continues her work at Alfaisal University, the future looks promising for Shimaa and her ongoing contributions to the scientific community.